APO Research
Talk to an analyst

APO RESEARCH · REPORT

Huntington Disease Protein

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Huntington Disease Protein Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025193 pages

Choose your research edition.

Industry ResearchHuntington Disease Protein Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Huntington Disease Protein Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Huntington Disease Protein Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Huntington Disease Protein Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Huntington Disease Protein Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Huntington Disease Protein market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Huntington Disease Protein is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Huntington Disease Protein is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Huntington Disease Protein is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Huntington Disease Protein is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Huntington Disease Protein include WAVE Life Sciences Ltd., Vybion, Inc., Voyager Therapeutics, Inc., UniQure N.V., Sangamo BioSciences, Inc., reMYND NV, nLife Therapeutics, S.L., Neurimmune Holding AG and Ionis Pharmaceuticals, Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Huntington Disease Protein market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Huntington Disease Protein and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Huntington Disease Protein sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Huntington Disease Protein market size, projected growth trends, production technologies, key applications, and end-use industries.

Huntington Disease Protein Segment by Company

WAVE Life Sciences Ltd.

Vybion, Inc.

Voyager Therapeutics, Inc.

UniQure N.V.

Sangamo BioSciences, Inc.

reMYND NV

nLife Therapeutics, S.L.

Neurimmune Holding AG

Ionis Pharmaceuticals, Inc.

AFFiRiS AG

Huntington Disease Protein Segment by Type

P-301905

NLF-HD

NI-302

IONIS-HTTRx

Others

Huntington Disease Protein Segment by Application

Kennedy's Disease

Spinocerebellar Ataxia

Alzheimer's Disease

Others

Huntington Disease Protein Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Huntington Disease Protein market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Huntington Disease Protein and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Huntington Disease Protein.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Huntington Disease Protein market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Huntington Disease Protein manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Huntington Disease Protein in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Huntington Disease Protein in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Huntington Disease Protein Industry Trends Table 2. Huntington Disease Protein Industry Drivers Table 3. Huntington Disease Protein Industry Opportunities and Challenges Table 4. Huntington Disease Protein Industry Restraints Table 5. Global Huntington Disease Protein Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Huntington Disease Protein Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Huntington Disease Protein Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Huntington Disease Protein Sales Market Share by Manufacturers Table 9. Global Huntington Disease Protein Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Huntington Disease Protein Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Huntington Disease Protein Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Huntington Disease Protein Manufacturers, Product Type & Application Table 13. Global Huntington Disease Protein Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Huntington Disease Protein by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of P-301905 Table 17. Major Manufacturers of NLF-HD Table 18. Major Manufacturers of NI-302 Table 19. Major Manufacturers of IONIS-HTTRx Table 20. Major Manufacturers of Others Table 21. Global Huntington Disease Protein Sales by Type 2021 VS 2025 VS 2032 (k units) Table 22. Global Huntington Disease Protein Sales by Type (2021-2026) & (k units) Table 23. Global Huntington Disease Protein Sales by Type (2027-2032) & (k units) Table 24. Global Huntington Disease Protein Sales Market Share by Type (2021-2026) Table 25. Global Huntington Disease Protein Sales Market Share by Type (2027-2032) Table 26. Global Huntington Disease Protein Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 27. Global Huntington Disease Protein Revenue by Type (2021-2026) & (k units) Table 28. Global Huntington Disease Protein Revenue by Type (2027-2032) & (k units) Table 29. Global Huntington Disease Protein Revenue Market Share by Type (2021-2026) Table 30. Global Huntington Disease Protein Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Kennedy's Disease Table 32. Major Manufacturers of Spinocerebellar Ataxia Table 33. Major Manufacturers of Alzheimer's Disease Table 34. Major Manufacturers of Others Table 35. Global Huntington Disease Protein Sales by Application 2021 VS 2025 VS 2032 (k units) Table 36. Global Huntington Disease Protein Sales by Application (2021-2026) & (k units) Table 37. Global Huntington Disease Protein Sales by Application (2027-2032) & (k units) Table 38. Global Huntington Disease Protein Sales Market Share by Application (2021-2026) Table 39. Global Huntington Disease Protein Sales Market Share by Application (2027-2032) Table 40. Global Huntington Disease Protein Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 41. Global Huntington Disease Protein Revenue by Application (2021-2026) & (k units) Table 42. Global Huntington Disease Protein Revenue by Application (2027-2032) & (k units) Table 43. Global Huntington Disease Protein Revenue Market Share by Application (2021-2026) Table 44. Global Huntington Disease Protein Revenue Market Share by Application (2027-2032) Table 45. Global Huntington Disease Protein Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 46. Global Huntington Disease Protein Sales by Region (2021-2026) & (k units) Table 47. Global Huntington Disease Protein Sales Market Share by Region (2021-2026) Table 48. Global Huntington Disease Protein Sales Forecasted by Region (2027-2032) & (k units) Table 49. Global Huntington Disease Protein Sales Forecasted Market Share by Region (2027-2032) Table 50. North America Huntington Disease Protein Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 51. North America Huntington Disease Protein Sales by Country (2021-2026) & (k units) Table 52. North America Huntington Disease Protein Sales by Country (2027-2032) & (k units) Table 53. Europe Huntington Disease Protein Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Europe Huntington Disease Protein Sales by Country (2021-2026) & (k units) Table 55. Europe Huntington Disease Protein Sales by Country (2027-2032) & (k units) Table 56. Asia Pacific Huntington Disease Protein Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 57. Asia Pacific Huntington Disease Protein Sales by Country (2021-2026) & (k units) Table 58. Asia Pacific Huntington Disease Protein Sales by Country (2027-2032) & (k units) Table 59. South America, Middle East and Africa Huntington Disease Protein Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 60. South America, Middle East and Africa Huntington Disease Protein Sales by Country (2021-2026) & (k units) Table 61. South America, Middle East and Africa Huntington Disease Protein Sales by Country (2027-2032) & (k units) Table 62. Global Huntington Disease Protein Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 63. Global Huntington Disease Protein Revenue by Region (2021-2026) & (US$ Million) Table 64. Global Huntington Disease Protein Revenue by Region (2027-2032) & (US$ Million) Table 65. Global Huntington Disease Protein Revenue Market Share by Region (2021-2026) Table 66. Global Huntington Disease Protein Revenue Market Share by Region (2027-2032) Table 67. WAVE Life Sciences Ltd. Company Information Table 68. WAVE Life Sciences Ltd. Business Overview Table 69. WAVE Life Sciences Ltd. Huntington Disease Protein Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. WAVE Life Sciences Ltd. Huntington Disease Protein Product Portfolio Table 71. WAVE Life Sciences Ltd. Recent Development Table 72. Vybion, Inc. Company Information Table 73. Vybion, Inc. Business Overview Table 74. Vybion, Inc. Huntington Disease Protein Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Vybion, Inc. Huntington Disease Protein Product Portfolio Table 76. Vybion, Inc. Recent Development Table 77. Voyager Therapeutics, Inc. Company Information Table 78. Voyager Therapeutics, Inc. Business Overview Table 79. Voyager Therapeutics, Inc. Huntington Disease Protein Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Voyager Therapeutics, Inc. Huntington Disease Protein Product Portfolio Table 81. Voyager Therapeutics, Inc. Recent Development Table 82. UniQure N.V. Company Information Table 83. UniQure N.V. Business Overview Table 84. UniQure N.V. Huntington Disease Protein Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. UniQure N.V. Huntington Disease Protein Product Portfolio Table 86. UniQure N.V. Recent Development Table 87. Sangamo BioSciences, Inc. Company Information Table 88. Sangamo BioSciences, Inc. Business Overview Table 89. Sangamo BioSciences, Inc. Huntington Disease Protein Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Sangamo BioSciences, Inc. Huntington Disease Protein Product Portfolio Table 91. Sangamo BioSciences, Inc. Recent Development Table 92. reMYND NV Company Information Table 93. reMYND NV Business Overview Table 94. reMYND NV Huntington Disease Protein Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. reMYND NV Huntington Disease Protein Product Portfolio Table 96. reMYND NV Recent Development Table 97. nLife Therapeutics, S.L. Company Information Table 98. nLife Therapeutics, S.L. Business Overview Table 99. nLife Therapeutics, S.L. Huntington Disease Protein Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. nLife Therapeutics, S.L. Huntington Disease Protein Product Portfolio Table 101. nLife Therapeutics, S.L. Recent Development Table 102. Neurimmune Holding AG Company Information Table 103. Neurimmune Holding AG Business Overview Table 104. Neurimmune Holding AG Huntington Disease Protein Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Neurimmune Holding AG Huntington Disease Protein Product Portfolio Table 106. Neurimmune Holding AG Recent Development Table 107. Ionis Pharmaceuticals, Inc. Company Information Table 108. Ionis Pharmaceuticals, Inc. Business Overview Table 109. Ionis Pharmaceuticals, Inc. Huntington Disease Protein Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Ionis Pharmaceuticals, Inc. Huntington Disease Protein Product Portfolio Table 111. Ionis Pharmaceuticals, Inc. Recent Development Table 112. AFFiRiS AG Company Information Table 113. AFFiRiS AG Business Overview Table 114. AFFiRiS AG Huntington Disease Protein Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. AFFiRiS AG Huntington Disease Protein Product Portfolio Table 116. AFFiRiS AG Recent Development Table 117. Key Raw Materials Table 118. Raw Materials Key Suppliers Table 119. Huntington Disease Protein Distributors List Table 120. Huntington Disease Protein Customers List Table 121. Research Programs/Design for This Report Table 122. Authors List of This Report Table 123. Secondary Sources Table 124. Primary Sources List of Figures Figure 1. Huntington Disease Protein Product Image Figure 2. Global Huntington Disease Protein Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Huntington Disease Protein Market Size (2021-2032) & (US$ Million) Figure 4. Global Huntington Disease Protein Sales (2021-2032) & (k units) Figure 5. Global Huntington Disease Protein Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Huntington Disease Protein Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. P-301905 Image Figure 9. NLF-HD Image Figure 10. NI-302 Image Figure 11. IONIS-HTTRx Image Figure 12. Others Image Figure 13. Global Huntington Disease Protein Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Huntington Disease Protein Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Huntington Disease Protein Sales Market Share by Type (2021-2032) Figure 16. Global Huntington Disease Protein Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 17. Global Huntington Disease Protein Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Huntington Disease Protein Revenue Market Share by Type (2021-2032) Figure 19. Kennedy's Disease Image Figure 20. Spinocerebellar Ataxia Image Figure 21. Alzheimer's Disease Image Figure 22. Others Image Figure 23. Global Huntington Disease Protein Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global Huntington Disease Protein Sales Market Share 2021 VS 2025 VS 2032 Figure 25. Global Huntington Disease Protein Sales Market Share by Application (2021-2032) Figure 26. Global Huntington Disease Protein Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 27. Global Huntington Disease Protein Revenue Market Share 2021 VS 2025 VS 2032 Figure 28. Global Huntington Disease Protein Revenue Market Share by Application (2021-2032) Figure 29. North America Huntington Disease Protein Sales and Growth Rate (2021-2032) & (k units) Figure 30. North America Huntington Disease Protein Sales Market Share by Country (2021-2032) Figure 31. U.S. Huntington Disease Protein Sales and Growth Rate (2021-2032) & (k units) Figure 32. Canada Huntington Disease Protein Sales and Growth Rate (2021-2032) & (k units) Figure 33. Mexico Huntington Disease Protein Sales and Growth Rate (2021-2032) & (k units) Figure 34. Europe Huntington Disease Protein Sales and Growth Rate (2021-2032) & (k units) Figure 35. Europe Huntington Disease Protein Sales Market Share by Country (2021-2032) Figure 36. Germany Huntington Disease Protein Sales and Growth Rate (2021-2032) & (k units) Figure 37. France Huntington Disease Protein Sales and Growth Rate (2021-2032) & (k units) Figure 38. U.K. Huntington Disease Protein Sales and Growth Rate (2021-2032) & (k units) Figure 39. Italy Huntington Disease Protein Sales and Growth Rate (2021-2032) & (k units) Figure 40. Netherlands Huntington Disease Protein Sales and Growth Rate (2021-2032) & (k units) Figure 41. Asia Pacific Huntington Disease Protein Sales and Growth Rate (2021-2032) & (k units) Figure 42. Asia Pacific Huntington Disease Protein Sales Market Share by Country (2021-2032) Figure 43. China Huntington Disease Protein Sales and Growth Rate (2021-2032) & (k units) Figure 44. Japan Huntington Disease Protein Sales and Growth Rate (2021-2032) & (k units) Figure 45. South Korea Huntington Disease Protein Sales and Growth Rate (2021-2032) & (k units) Figure 46. Southeast Asia Huntington Disease Protein Sales and Growth Rate (2021-2032) & (k units) Figure 47. India Huntington Disease Protein Sales and Growth Rate (2021-2032) & (k units) Figure 48. Australia Huntington Disease Protein Sales and Growth Rate (2021-2032) & (k units) Figure 49. South America, Middle East and Africa Huntington Disease Protein Sales and Growth Rate (2021-2032) & (k units) Figure 50. South America, Middle East and Africa Huntington Disease Protein Sales Market Share by Country (2021-2032) Figure 51. Brazil Huntington Disease Protein Sales and Growth Rate (2021-2032) & (k units) Figure 52. South Africa Huntington Disease Protein Sales and Growth Rate (2021-2032) & (k units) Figure 53. Saudi Arabia Huntington Disease Protein Sales and Growth Rate (2021-2032) & (k units) Figure 54. Turkey Huntington Disease Protein Sales and Growth Rate (2021-2032) & (k units) Figure 55. Argentina Huntington Disease Protein Sales and Growth Rate (2021-2032) & (k units) Figure 56. UAE Huntington Disease Protein Sales and Growth Rate (2021-2032) & (k units) Figure 57. Egypt Huntington Disease Protein Sales and Growth Rate (2021-2032) & (k units) Figure 58. Chile Huntington Disease Protein Sales and Growth Rate (2021-2032) & (k units) Figure 59. Global Huntington Disease Protein Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Global Huntington Disease Protein Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 61. North America Huntington Disease Protein Revenue (2021-2032) & (US$ Million) Figure 62. North America Huntington Disease Protein Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Europe Huntington Disease Protein Revenue (2021-2032) & (US$ Million) Figure 64. Europe Huntington Disease Protein Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Asia-Pacific Huntington Disease Protein Revenue (2021-2032) & (US$ Million) Figure 66. Asia-Pacific Huntington Disease Protein Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. South America, Middle East and Africa Huntington Disease Protein Revenue (2021-2032) & (US$ Million) Figure 68. South America, Middle East and Africa Huntington Disease Protein Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 69. Huntington Disease Protein Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Huntington Disease Protein Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • P-301905
  • NLF-HD
  • NI-302
  • IONIS-HTTRx
  • Others
Applications
  • Kennedy's Disease
  • Spinocerebellar Ataxia
  • Alzheimer's Disease
  • Others
Companies covered
  • WAVE Life Sciences Ltd.
  • Vybion, Inc.
  • Voyager Therapeutics, Inc.
  • UniQure N.V.
  • Sangamo BioSciences, Inc.
  • reMYND NV
  • nLife Therapeutics, S.L.
  • Neurimmune Holding AG
  • Ionis Pharmaceuticals, Inc.
  • AFFiRiS AG

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Huntington Disease Protein Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Huntington Disease Protein Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Huntington Disease Protein Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Huntington Disease Protein Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Huntington Disease Protein Market Dynamics
  1. 2.1 Huntington Disease Protein Industry Trends
  2. 2.2 Huntington Disease Protein Industry Drivers
  3. 2.3 Huntington Disease Protein Industry Opportunities and Challenges
  4. 2.4 Huntington Disease Protein Industry Restraints
3 Huntington Disease Protein Market by Manufacturers
  1. 3.1 Global Huntington Disease Protein Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Huntington Disease Protein Sales by Manufacturers (2021-2026)
  3. 3.3 Global Huntington Disease Protein Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Huntington Disease Protein Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Huntington Disease Protein Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Huntington Disease Protein Manufacturers, Product Type & Application
  7. 3.7 Global Huntington Disease Protein Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Huntington Disease Protein Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Huntington Disease Protein Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Huntington Disease Protein Tier 1, Tier 2, and Tier 3
4 Huntington Disease Protein Market by Type
  1. 4.1 Huntington Disease Protein Type Introduction
  2. 4.1.1 P-301905
  3. 4.1.2 NLF-HD
  4. 4.1.3 NI-302
  5. 4.1.4 IONIS-HTTRx
  6. 4.1.5 Others
  7. 4.2 Global Huntington Disease Protein Sales by Type
  8. 4.2.1 Global Huntington Disease Protein Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Huntington Disease Protein Sales by Type (2021-2032)
  10. 4.2.3 Global Huntington Disease Protein Sales Market Share by Type (2021-2032)
  11. 4.3 Global Huntington Disease Protein Revenue by Type
  12. 4.3.1 Global Huntington Disease Protein Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Huntington Disease Protein Revenue by Type (2021-2032)
  14. 4.3.3 Global Huntington Disease Protein Revenue Market Share by Type (2021-2032)
5 Huntington Disease Protein Market by Application
  1. 5.1 Huntington Disease Protein Application Introduction
  2. 5.1.1 Kennedy's Disease
  3. 5.1.2 Spinocerebellar Ataxia
  4. 5.1.3 Alzheimer's Disease
  5. 5.1.4 Others
  6. 5.2 Global Huntington Disease Protein Sales by Application
  7. 5.2.1 Global Huntington Disease Protein Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Huntington Disease Protein Sales by Application (2021-2032)
  9. 5.2.3 Global Huntington Disease Protein Sales Market Share by Application (2021-2032)
  10. 5.3 Global Huntington Disease Protein Revenue by Application
  11. 5.3.1 Global Huntington Disease Protein Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Huntington Disease Protein Revenue by Application (2021-2032)
  13. 5.3.3 Global Huntington Disease Protein Revenue Market Share by Application (2021-2032)
6 Global Huntington Disease Protein Sales by Region
  1. 6.1 Global Huntington Disease Protein Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Huntington Disease Protein Sales by Region (2021-2032)
  3. 6.2.1 Global Huntington Disease Protein Sales by Region (2021-2026)
  4. 6.2.2 Global Huntington Disease Protein Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Huntington Disease Protein Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Huntington Disease Protein Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Huntington Disease Protein Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Huntington Disease Protein Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Huntington Disease Protein Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Huntington Disease Protein Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Huntington Disease Protein Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Huntington Disease Protein Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Huntington Disease Protein Revenue by Region
  1. 7.1 Global Huntington Disease Protein Revenue by Region
  2. 7.1.1 Global Huntington Disease Protein Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Huntington Disease Protein Revenue by Region (2021-2026)
  4. 7.1.3 Global Huntington Disease Protein Revenue by Region (2027-2032)
  5. 7.1.4 Global Huntington Disease Protein Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Huntington Disease Protein Revenue (2021-2032)
  8. 7.2.2 North America Huntington Disease Protein Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Huntington Disease Protein Revenue (2021-2032)
  11. 7.3.2 Europe Huntington Disease Protein Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Huntington Disease Protein Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Huntington Disease Protein Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Huntington Disease Protein Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Huntington Disease Protein Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 WAVE Life Sciences Ltd.
  2. 8.1.1 WAVE Life Sciences Ltd. Company Information
  3. 8.1.2 WAVE Life Sciences Ltd. Business Overview
  4. 8.1.3 WAVE Life Sciences Ltd. Huntington Disease Protein Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 WAVE Life Sciences Ltd. Huntington Disease Protein Product Portfolio
  6. 8.1.5 WAVE Life Sciences Ltd. Recent Developments
  7. 8.2 Vybion, Inc.
  8. 8.2.1 Vybion, Inc. Company Information
  9. 8.2.2 Vybion, Inc. Business Overview
  10. 8.2.3 Vybion, Inc. Huntington Disease Protein Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Vybion, Inc. Huntington Disease Protein Product Portfolio
  12. 8.2.5 Vybion, Inc. Recent Developments
  13. 8.3 Voyager Therapeutics, Inc.
  14. 8.3.1 Voyager Therapeutics, Inc. Company Information
  15. 8.3.2 Voyager Therapeutics, Inc. Business Overview
  16. 8.3.3 Voyager Therapeutics, Inc. Huntington Disease Protein Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Voyager Therapeutics, Inc. Huntington Disease Protein Product Portfolio
  18. 8.3.5 Voyager Therapeutics, Inc. Recent Developments
  19. 8.4 UniQure N.V.
  20. 8.4.1 UniQure N.V. Company Information
  21. 8.4.2 UniQure N.V. Business Overview
  22. 8.4.3 UniQure N.V. Huntington Disease Protein Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 UniQure N.V. Huntington Disease Protein Product Portfolio
  24. 8.4.5 UniQure N.V. Recent Developments
  25. 8.5 Sangamo BioSciences, Inc.
  26. 8.5.1 Sangamo BioSciences, Inc. Company Information
  27. 8.5.2 Sangamo BioSciences, Inc. Business Overview
  28. 8.5.3 Sangamo BioSciences, Inc. Huntington Disease Protein Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Sangamo BioSciences, Inc. Huntington Disease Protein Product Portfolio
  30. 8.5.5 Sangamo BioSciences, Inc. Recent Developments
  31. 8.6 reMYND NV
  32. 8.6.1 reMYND NV Company Information
  33. 8.6.2 reMYND NV Business Overview
  34. 8.6.3 reMYND NV Huntington Disease Protein Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 reMYND NV Huntington Disease Protein Product Portfolio
  36. 8.6.5 reMYND NV Recent Developments
  37. 8.7 nLife Therapeutics, S.L.
  38. 8.7.1 nLife Therapeutics, S.L. Company Information
  39. 8.7.2 nLife Therapeutics, S.L. Business Overview
  40. 8.7.3 nLife Therapeutics, S.L. Huntington Disease Protein Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 nLife Therapeutics, S.L. Huntington Disease Protein Product Portfolio
  42. 8.7.5 nLife Therapeutics, S.L. Recent Developments
  43. 8.8 Neurimmune Holding AG
  44. 8.8.1 Neurimmune Holding AG Company Information
  45. 8.8.2 Neurimmune Holding AG Business Overview
  46. 8.8.3 Neurimmune Holding AG Huntington Disease Protein Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Neurimmune Holding AG Huntington Disease Protein Product Portfolio
  48. 8.8.5 Neurimmune Holding AG Recent Developments
  49. 8.9 Ionis Pharmaceuticals, Inc.
  50. 8.9.1 Ionis Pharmaceuticals, Inc. Company Information
  51. 8.9.2 Ionis Pharmaceuticals, Inc. Business Overview
  52. 8.9.3 Ionis Pharmaceuticals, Inc. Huntington Disease Protein Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Ionis Pharmaceuticals, Inc. Huntington Disease Protein Product Portfolio
  54. 8.9.5 Ionis Pharmaceuticals, Inc. Recent Developments
  55. 8.10 AFFiRiS AG
  56. 8.10.1 AFFiRiS AG Company Information
  57. 8.10.2 AFFiRiS AG Business Overview
  58. 8.10.3 AFFiRiS AG Huntington Disease Protein Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 AFFiRiS AG Huntington Disease Protein Product Portfolio
  60. 8.10.5 AFFiRiS AG Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Huntington Disease Protein Value Chain Analysis
  2. 9.1.1 Huntington Disease Protein Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Huntington Disease Protein Production Mode & Process
  6. 9.2 Huntington Disease Protein Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Huntington Disease Protein Distributors
  9. 9.2.3 Huntington Disease Protein Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst